Sun Pharma Advanced Research Company (SPARC) today reported a net loss of Rs 1.65 crore for the first quarter ended June 30, 2015-16.
The company had reported a net loss of 9.74 crore during the same period of previous fiscal, 2014-15.
Income from operations rose to Rs 43.44 crore for the first quarter of the current fiscal, as against Rs 35.85 crore in the same period of previous fiscal, SPARC Ltd said in a filing to the BSE.
SPARC was demerged from Sun Pharma as a pharma research and drug discovery company in 2007.
